The recent article discusses the limits of genetics in understanding schizophrenia, emphasizing that while genetic research is crucial for disease elucidation, psychiatric disorders may require alternative approaches. It suggests utilizing human neural organoids, neuroimaging, and better biomarkers to explore the cellular and systemic changes linked to schizophrenia. The article notes that behavioral and psychiatric conditions often involve malfunctioning neural circuits without obvious cellular damage. To address these complexities, integrating genetic information with findings from these emerging methods could lead to more effective treatment strategies.
What should we conclude? I certainly don't question the value of searching for genes that cause or confer susceptibility to disease and provide therapeutic targets.
In the realm of the brain, genetic approaches may be more valuable in studies of neurodegenerative or neurological disorders than those in which circuits appear to malfunction.
Unraveling schizophrenia... will likely need to rely more heavily on other methods... to seek cellular and molecular changes, and neuroimaging to seek systems-level perturbations.
In the long run, results from these emerging methods could be combined with genetic data to teach us how schizophrenia happens and how to treat it effectively.
Collection
[
|
...
]